TY - JOUR ID - 57593 TI - Analysis of the Expression of Surface Receptors on NK Cells and NKG2D on Immunocytes in Peripheral Blood of Patients with Nasopharyngeal Carcinoma JO - Asian Pacific Journal of Cancer Prevention JA - APJCP LA - en SN - 1513-7368 AU - Xu, Yuanji AU - Zhou, Rui AU - Huang, Chuanzhong AU - Zhang, Mingwei AU - Li, Jieyu AU - Zong, Jingfeng AU - Qiu, Sufang AU - Lin, Shaojun AU - Chen, Honglin AU - Ye, Yunbin AU - Pan, Jianji AD - Department of Radiation Oncology, Fujian Cancer Hospital, Fujian Medical University Cancer Hospita, Fuzhou, Fujian, China AD - Laboratory of Immuno-Oncology, Fujian Cancer Hospital, Fujian Medical University Cancer Hospita, Fuzhou, Fujian, China. AD - Department of Radiotherapy, First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian,China. AD - State Key Laboratory for Emerging Infectious Diseases, Department of Microbiology and the Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The University of Hong Kong, Hong Kong SAR, China. Y1 - 2018 PY - 2018 VL - 19 IS - 3 SP - 661 EP - 665 KW - Nasopharyngeal carcinoma KW - surface receptors KW - NK cells KW - NKG2D KW - Flow Cytometry DO - 10.22034/APJCP.2018.19.3.661 N2 - Background: The aberrant expression of surface receptors on immunocytes may represent potential markers of tumorescape for nasopharyngeal carcinoma (NPC). The aim of this study was to investigate the expression of representativereceptors on natural killer (NK) cells and NK group 2, member D (NKG2D) on immunocytes in the peripheral bloodof patients with NPC. Methods: Patients (n = 64) with NPC prior to initiation of treatment were defined as the studygroup. Healthy volunteers (n = 31) served as the control group. The expression of NK cells and NKT cells; the triggeringreceptors NKp30, NKp44, and NKp46 on NK cells; the activating receptor NKG2D on NK cells, CD4+ T cells, andCD8+ T cells; and the inhibitory receptors CD158b and CD159a on NK cells were analyzed by flow cytometry in thetwo groups. Results: Here, our study showed that no differences were observed in terms of the numbers of NK cells orNKT cells, or the expression of CD158b and CD159a on the surface of NK cells between the two groups. Nevertheless,the expression levels of NKp30 and NKp46 on NK cells in the NPC patients were significantly lower than in the healthyindividuals (P < 0.05). No differences existed in the expression of NKG2D on NK cells, but NKG2D on CD8+ T cellsshowed a markedly lower expression in the study group (P < 0.001). Conclusions: Our findings may reflect a possiblemechanism of immune evasion for NPC. The enhancement of immunotherapy concerning NKp30, NKp46, and NKG2Dmay be an innovative treatment strategy for patients with NPC. UR - https://journal.waocp.org/article_57593.html L1 - https://journal.waocp.org/article_57593_e5ff6471af84ec8a695a8881fa439ea2.pdf ER -